Gut Bacteria‑Produced Molecule Linked to Higher Alzheimer’s Risk

Researchers have identified a compound produced by gut bacteria, called ImP, that is associated with an increased risk of Alzheimer’s disease. The study found that higher levels of ImP in the bloodstream correlate with greater accumulation of harmful brain proteins and a more rapid decline in cognitive function. These findings suggest that ImP may play a role in the development and progression of Alzheimer’s, and that strategies to lower its concentration in the blood could potentially slow or prevent the disease. Further research is needed to confirm the mechanism and to explore therapeutic interventions targeting ImP.